Pegasys peginterferon: Expanded Phase IV

ROCZ expanded an open-label U.S. and Puerto Rican Phase IV trial of Pegasys plus Copegus to enroll 540 interferon-naïve genotype-1 chronic HCV patients. The trial will evaluate response rates in 270 ...